• 1
    Fenton MJ, Golenbock DT. LPS-binding proteins and receptors. J Leukoc Biol 1998; 64: 2532.
  • 2
    Means TK, Lien E, Yoshimura A, Wang S, Golenbock DT, Fenton MJ. The CD14 ligands lipoarabinomannan and lipopolysaccharide differ in their requirement for Toll-like receptors. J Immunol 1999; 163: 674855.
  • 3
    Beutler B. Tlr4: central component of the sole mammalian LPS sensor. Curr Opin Immunol 2000; 12: 206.
  • 4
    Flaherty SF, Golenbock DT, Milham FH, Ingalls RR. CD11/CD18 leukocyte integrins: new signaling receptors for bacterial endotoxin. J Surg Res 1997; 73: 859.DOI: 10.1006/jsre.1997.5195
  • 5
    Medvedev AE, Flo T, Ingalls RR, Golenbock DT, Teti G, Vogel SN, Espevik T. Involvement of CD14 and complement receptors CR3 and CR4 in nuclear factor-kappaB activation and TNF production induced by lipopolysaccharide and group B streptococcal cell walls. J Immunol 1998; 160: 453542.
  • 6
    Tohme ZN, Amar S, Van Dyke TE. Moesin functions as a lipopolysaccharide receptor on human monocytes. Infect Immun 1999; 67: 321520.
  • 7
    Todd RF 3rd, Petty HR. Beta 2 (CD11/CD18) integrins can serve as signaling partners for other leukocyte receptors. J Lab Clin Med 1997; 129: 4928.DOI: 10.1016/S0022-2143(97)90003-2
  • 8
    Perera PY, Mayadas TN, Takeuchi O, Akira S, Zaks-Zilberman M, Goyert SM, Vogel SN. CD11b/CD18 acts in concert with CD14 and Toll-like receptor (TLR) 4 to elicit full lipopolysaccharide and taxol-inducible gene expression. J Immunol 2001; 166: 57481.
  • 9
    Tracey KJ, Beutler B, Lowry SF et al. Shock and tissue injury induced by recombinant human cachectin. Science 1986; 234: 4704.
  • 10
    Karima R, Matsumoto S, Higashi H, Matsushima K. The molecular pathogenesis of endotoxic shock and organ failure. Mol Med Today 1999; 5: 12332.DOI: 10.1016/S1357-4310(98)01430-0
  • 11
    Beutler B, Milsark IW, Cerami AC. Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin. Science 1985; 229: 86971.
  • 12
    Baumann H, Gauldie J. The acute phase response. Immunol Today 1994; 15: 7480.
  • 13
    Baseler MW, Burrell R. Purification of haptoglobin and its effects on lymphocyte and alveolar macrophage responses. Inflammation 1983; 7: 387400.
  • 14
    Oh SK, Kim SH, Walker JE. Interference with immune response at the level of generating effector cells by tumor-associated haptoglobin. J Natl Cancer Inst 1990; 82: 93440.
  • 15
    Oh SK, Pavlotsky N, Tauber AI. Specific binding of haptoglobin to human neutrophils and its functional consequences. J Leukoc Biol 1990; 47: 1428.
  • 16
    Oh SK, Ross S, Walker J, Zeisel S. Role of a SER immune suppressor in immune surveillance. Immunology 1988; 64: 739.
  • 17
    Jeannin P, Lecoanet-Henchoz S, Delneste Y, Gauchat JF, Bonnefoy JY. Alpha-1 antitrypsin up-regulates human B cell differentiation selectively into IgE- and IgG4-secreting cells. Eur J Immunol 1998; 28: 181522.DOI: 10.1002/(SICI)1521-4141(199806)28:06<1815::AID-IMMU1815>3.0.CO;2-5
  • 18
    Kendall PA, Saeed SA, Collier HO. Identification of endogenous inhibitor of prostaglandin synthetase with haptoglobin and albumin [proceedings]. Biochem Soc Trans 1979; 7: 5435.
  • 19
    Bennett M, Schmid K. Immunosuppression by human plasma alpha 1-acid glycoprotein: importance of the carbohydrate moiety. Proc Natl Acad Sci USA 1980; 77: 610913.
  • 20
    Hennet T, Chui D, Paulson JC, Marth JD. Immune regulation by the ST6Gal sialyltransferase. Proc Natl Acad Sci USA 1998; 95: 45049.DOI: 10.1073/pnas.95.8.4504
  • 21
    Grey ST, Tsuchida A, Hau H, Orthner CL, Salem HH, Hancock WW. Selective inhibitory effects of the anticoagulant activated protein C on the responses of human mononuclear phagocytes to LPS, IFN-gamma, or phorbol ester. J Immunol 1994; 153: 366472.
  • 22
    Buckley CD, Pilling D, Henriquez NV et al. RGD peptides induce apoptosis by direct caspase-3 activation. Nature 1999; 397: 5349.DOI: 10.1038/17409
  • 23
    Pagano M, Nicola MA, Engler R. Inhibition of cathepsin L and B by haptoglobin, the haptoglobin-hemoglobin complex, and asialohaptoglobin. ‘In vitro’ studies in the rat. Can J Biochem 1982; 60: 6317.
  • 24
    Saeed SA, Mahmood F, Shah BH, Gilani AH. The inhibition of prostaglandin biosynthesis by human haptoglobin and its relationship with haemoglobin binding. Biochem Soc Trans 1997; 25: S618.
  • 25
    Arredouani M, Ceuppens JL. Haptoglobin – a new link between innate and adaptive immunity. Curr Trends Immunol 2002; 4: 7383.
  • 26
    Samak R, Edelstein R, Israel L. Immunosuppressive effect of acute-phase reactant proteins in vitro and its relevance to cancer. Cancer Immunol Immunother 1982; 13: 3843.
  • 27
    Arredouani M, Matthijs P, Van Hoeyveld E, Kasran A, Baumann H, Ceuppens JL, Stevens E. Haptoglobin directly affects T cells and suppresses T helper cell type 2 cytokine release. Immunology 2003; 108: 14451.DOI: 10.1046/j.1365-2567.2003.01569.x
  • 28
    Arredouani M, Matthys P, Kasran A, Baumann H, Ceuppen JL. Haptoglobin and the Th1/Th2 balance. hints from in vitro and in vivo studies. Redox Rep 2001; 6: 36971.
  • 29
    Wagner L, Gessl A, Parzer SB, Base W, Waldhausl W, Pasternack MS. Haptoglobin phenotyping by newly developed monoclonal antibodies. Demonstration of haptoglobin uptake into peripheral blood neutrophils and monocytes. J Immunol 1996; 156: 198996.
  • 30
    Berkova N, Gilbert C, Goupil S, Yan J, Korobko V, Naccache PH. TNF-induced haptoglobin release from human neutrophils. Pivotal role of the TNF p55 receptor. J Immunol 1999; 162: 622632.
  • 31
    El Ghmati SM, Van Hoeyveld EM, Van Strijp JG, Ceuppens JL, Stevens EA. Identification of haptoglobin as an alternative ligand for CD11b/CD18. J Immunol 1996; 156: 254252.
  • 32
    El-Ghmati SM, Arredouani M, Van Hoeyveld EM, Ceuppens JL, Stevens EA. Haptoglobin interacts with the human mast cell line HMC-1 and inhibits its spontaneous proliferation. Scand J Immunol 2002; 55: 3528.DOI: 10.1046/j.1365-3083.2002.01067.x
  • 33
    Hanasaki K, Powell LD, Varki A. Binding of human plasma sialoglycoproteins by the B cell-specific lectin CD22. Selective recognition of immunoglobulin M and haptoglobin. J Biol Chem 1995; 270: 754350.DOI: 10.1074/jbc.270.13.7543
  • 34
    Elson EC. Quantitative determination of serum haptoglobin. A simple and rapid method. Am J Clin Pathol 1974; 62: 65563.
  • 35
    Lim SK, Kim H, Bin Ali A, Lim YK, Wang Y, Chong SM, Costantini F, Baumman H. Increased susceptibility in Hp knockout mice during acute hemolysis. Blood 1998; 92: 18707.
  • 36
    Lefort J, Singer M, Leduc D et al. Systemic administration of endotoxin induces bronchopulmonary hyperreactivity dissociated from TNF-alpha formation and neutrophil sequestration into the murine lungs. J Immunol 1998; 161: 47480.
  • 37
    Hamelmann E, Schwarze J, Takeda K, Oshiba A, Larsen GL, Irvin CG, Gelfand EW. Noninvasive measurement of airway responsiveness in allergic mice using barometric plethysmography. Am J Respir Crit Care Med 1997; 156: 76675.
  • 38
    Held TK, Weihua X, Yuan L, Kalvakolanu DV, Cross AS. Gamma interferon augments macrophage activation by lipopolysaccharide by two distinct mechanisms, at the signal transduction level and via an autocrine mechanism involving tumor necrosis factor alpha and interleukin-1. Infect Immun 1999; 67: 20612.
  • 39
    Most J, Schwaeble W, Drach J, Sommerauer A, Dierich MP. Regulation of the expression of ICAM-1 on human monocytes and monocytic tumor cell lines. J Immunol 1992; 148: 163542.
  • 40
    Bazil V, Strominger JL. Shedding as a mechanism of down-modulation of CD14 on stimulated human monocytes. J Immunol 1991; 147: 156774.
  • 41
    Marth T, Kelsall BL. Regulation of interleukin-12 by complement receptor 3 signaling. J Exp Med 1997; 185: 198795.DOI: 10.1084/jem.185.11.1987
  • 42
    Attanasio M, Gori AM, Giusti B et al. Cytokine gene expression in human LPS- and IFNgamma-stimulated mononuclear cells is inhibited by heparin. Thromb Haemost 1998; 79: 95962.
  • 43
    Rezzonico R, Chicheportiche R, Imbert V, Dayer JM. Engagement of CD11b and CD11c beta2 integrin by antibodies or soluble CD23 induces IL-1beta production on primary human monocytes through mitogen-activated protein kinase-dependent pathways. Blood 2000; 95: 386877.
  • 44
    Gutierrez-Ramos JC, Bluethmann H. Molecules and mechanisms operating in septic shock: lessons from knockout mice. Immunol Today 1997; 18: 32934.DOI: 10.1016/S0167-5699(97)01085-2
  • 45
    Netea MG, De Bont N, Demacker PN, Kullberg BJ, Jacobs LE, Verver-Jansen TJ, Stalenhoef AF, Van der Meer JW. Lipoprotein(a) inhibits lipopolysaccharide-induced tumor necrosis factor alpha production by human mononuclear cells. Infect Immun 1998; 66: 23657.
  • 46
    Baveye S, Elass E, Mazurier J, Spik G, Legrand D. Lactoferrin: a multifunctional glycoprotein involved in the modulation of the inflammatory process. Clin Chem Lab Med 1999; 37: 2816.
  • 47
    Wittmann M, Zwirner J, Larsson VA, Kirchhoff K, Begemann G, Kapp A, Gotze O, Werfel T. C5a suppresses the production of IL-12 by IFN-gamma-primed and lipopolysaccharide-challenged human monocytes. J Immunol 1999; 162: 67639.
  • 48
    D'Andrea A, Ma X, Aste-Amezaga M, Paganin C, Trinchieri G. Stimulatory and inhibitory effects of interleukin (IL)-4 and IL-13 on the production of cytokines by human peripheral blood mononuclear cells: priming for IL-12 and tumor necrosis factor alpha production. J Exp Med 1995; 181: 53746.DOI: 10.1084/jem.181.2.537
  • 49
    Jue DM, Shim BS, Kang YS. Inhibition of prostaglandin synthase activity of sheep seminal vesicular gland by human serum haptoglobin. Mol Cell Biochem 1983; 51: 1417.
  • 50
    Troelstra A, Antal-Szalmas P, De Graaf-Miltenburg LA, Weersink AJ, Verhoef J, Van Kessel KP, Van Strijp JA. Saturable CD14-dependent binding of fluorescein-labeled lipopolysaccharide to human monocytes. Infect Immun 1997; 65: 22727.